TITLE

Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine

AUTHOR(S)
Qi Zhang; Lin Lu; LiJin Pu; RuiYan Zhang; Jie Shen; ZhengBing Zhu; Jian Hu; ZhenKun Yang; QiuJin Chen; WeiFeng Shen
PUB. DATE
January 2007
SOURCE
Cardiovascular Diabetology;2007, Vol. 6, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Observational clinical studies have shown that patients with diabetes have less favorable results after percutaneous coronary intervention compared with the non-diabetic counterparts, but its mechanism remains unclear. The aim of this study was to examine the changes of neointimal hyperplasia after sirolimus-eluting stent (SES) implantation in a diabetic porcine model, and to evaluate the impact of aortic inflammation on this proliferative process. Methods: Diabetic porcine model was created with an intravenous administration of a single dose of streptozotocin in 15 Chinese Guizhou minipigs (diabetic group); each of them received 2 SES (Firebird, Microport Co, China) implanted into 2 separated major epicardial coronary arteries. Fifteen non-diabetic minipigs with SES implantation served as controls (control group). At 6 months, the degree of neointimal hyperplasia was determined by repeat coronary angiography, intravascular ultrasound (IVUS) and histological examination. Tumor necrosis factor (TNF)-α protein level in the aortic intima was evaluated by Western blotting, and TNF-α, interleukin (IL)- 1β and IL-6 mRNA levels were assayed by reverse transcription and polymerase chain reaction. Results: The distribution of stented vessels, diameter of reference vessels, and post-procedural minimal lumen diameter were comparable between the two groups. At 6-month follow-up, the degree of in-stent restenosis (40.4 ± 24.0% vs. 20.2 ± 17.7%, p < 0.05), late lumen loss (0.33 ± 0.19 mm vs. 0.10 ± 0.09 mm, p < 0.001) by quantitative angiography, percentage of intimal hyperplasia in the stented area (26.7 ± 19.2% vs. 7.3 ± 6.1%, p < 0.001) by IVUS, and neointimal area (1.59 ± 0.76 mm² vs. 0.41 ± 0.18 mm², p < 0.05) by histological examination were significantly exacerbated in the diabetic group than those in the controls. Significant increases in TNF-α protein and TNF-α, IL-1β and IL-6 mRNA levels were observed in aortic intima in the diabetic group. Conclusion: Neointimal hyperplasia persisted at least up to 6 months after SES implantation in diabetic porcine, which may be partly related to an exaggerated inflammatory response within the blood vessel wall. Our results provide theoretical support for potential direct beneficial effects of anti-diabetic and anti-inflammation medications in reducing the risk of restenosis after stenting.
ACCESSION #
28682827

 

Related Articles

  • Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state Influence of HbA1c on healing of carotid stents. Willfort-Ehringer, A.; Ahmadi, R.; Gessl, A.; Gschwandtner, M. E.; Haumer, A.; Lang, W.; Minar, E.; Zehetmayer, S.; Ehringer, H. // Diabetologia;Mar2004, Vol. 47 Issue 3, p400 

    Aims/hypothesis. We studied the influence of initial hyperglycaemia on neointimal proliferation within carotid Wallstents. Methods. A total of 112 patients were followed by duplex sonography after carotid stenting for 24 months. Patients were assigned to three groups: non-diabetic subjects...

  • EVALUATION OF HYPOGLYCEMIC EFFECT OF COW URINE DISTILLATE IN STREPTOZOTOCIN INDUCED DIABETIC RAT MODEL. M. KADAGI; K. JAYAKUMAR; N. B. SHRIDHAR; H. D. NARAYANASWAMY; M. NARAYANASWAMY; K. P. MANJUNATHA // Journal of Cell & Tissue Research;2012, Vol. 12 Issue 3, p3317 

    The present study was designed to determine the hypoglycemic activity of cow urine distillate in streptozotocin induced diabetic rats. The Wister albino rats were divided into five groups (n=10). Group I served as normal control. Diabetes was induced in group II to V by injecting streptozotocin....

  • Erratum to: Two novel mutations in CYP11B1 and modeling the consequent alterations of the translated protein in classic congenital adrenal hyperplasia patients. Abbaszadegan, Mohammad; Hassani, Soolmaz; Vakili, Rahim; Saberi, Mohammad; Baradaran-Heravi, Alireza; A'rabi, Azadeh; Hashemipour, Mahin; Razzaghi-Azar, Maryam; Moaven, Omeed; Baratian, Ali; Ahadian, Mitra; Keify, Fatemeh; Meurice, Nathalie // Endocrine (1355008X);Aug2013, Vol. 44 Issue 1, p271 

    A correction to the article "Two novel mutations in CYP11B1 and modeling the consequent alterations of the translated protein in classic congenital adrenal hyperplasia patients" published in the online edition of April 20, 2013 issue of the periodical is presented.

  • Azathioprine.  // Reactions Weekly;6/26/2010, Issue 1307, p15 

    The article presents the case of a 54-year-old man who developed hepatic nodular regenerative hyperplasia while receiving azathioprine for Crohn's disease.

  • Mercaptopurine.  // Reactions Weekly;3/19/2011, Issue 1343, p24 

    The article describes the case of a 56-year-old man who developed nodular regenerative hyperplasia and portal hypertension while receiving treatment with mercaptopurine.

  • Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Han, E. K.-H.; Leverson, J. D.; McGonigal, T.; Shah, O. J.; Woods, K. W.; Hunter, T.; Giranda, V. L.; Luo, Y. // Oncogene;8/16/2007, Vol. 26 Issue 38, p5655 

    Rapamycin, a natural product inhibitor of the Raptor-mammalian target of rapamycin complex (mTORC1), is known to induce Protein kinase B (Akt/PKB) Ser-473 phosphorylation in a subset of human cancer cell lines through inactivation of S6K1, stabilization of insulin receptor substrate (IRS)-1, and...

  • Clinical Trial Aims to Save Functioning Beta Cells in Newly Diagnosed Patients.  // Countdown;Winter2000, Vol. 21 Issue 1, p16 

    Reports on the planned clinical trial to test the safety, tolerability and effects of an immunosuppressive agent for the treatment of Type 1 diabetes. Testing of the genetically modified form of a drug known as OKT3; Possibility that treatment may prevent the deterioration in insulin secretory...

  • Immunosuppressants.  // Reactions Weekly;7/6/2013, Issue 1460, p26 

    The article presents a case study of a 55-year-old man with the history of diabetes mellitus and who developed Ochroconis gallopava infection after receiving immunosuppressant therapy with antithymocyte globulin.

  • Sclerosing lobular hyperplasia: sonographic pathologic correlation. Nariya Cho; Ki Keun Oh; Kae Young Park; Tae Woong Noh // European Radiology;Jul2003, Vol. 13 Issue 7, p1645 

    The objective was to evaluate the sonographic findings of sclerosing lobular hyperplasia (SLH) of the breast and to correlate the sonographic findings and the pathologic features. This study consisted of 9 patients with pathologically proven sclerosing lobular hyperplasia who had undergone a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics